LAV Biosciences Fund V, L.P.

Insider CIK 1764435 · ADRX 10% owner · TERN 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	360,577	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	360,577	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	180,288	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	601,161	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	1,953,774	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	10,438,412	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	1,667,469	—	$0	10,576,244	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	307,738	—	$0	307,738	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	153,868	—	$0	11,243,179	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	307,738	—	$0	307,738	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	8,908,775	—	$0	8,908,775	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	513,067	—	$0	11,089,311	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	360,577	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	360,577	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	180,288	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	601,161	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	1,953,774	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion deriv	2026-09-28	2026-09-29	10,438,412	—	$0	0	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	307,738	—	—	307,738	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	307,738	—	—	307,738	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	153,868	—	—	11,243,179	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	513,067	—	—	11,089,311	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	1,667,469	—	—	10,576,244	SEC↗
ADRX ADARx Pharmaceuticals, Inc	C Conversion	2026-09-28	2026-09-29	8,908,775	—	—	8,908,775	SEC↗
TERN Terns Pharmaceuticals, Inc	S Sale	2022-11-23	2022-11-28	166,666	$5.50	$916.7K	529,762	SEC↗
TERN Terns Pharmaceuticals, Inc	S Sale	2022-11-23	2022-11-28	333,334	$5.50	$1.83M	1,059,523	SEC↗
TERN Terns Pharmaceuticals, Inc	S Sale	2022-11-23	2022-11-28	1,000,000	$5.50	$5.50M	405,583	SEC↗
TERN Terns Pharmaceuticals, Inc	C Conversion deriv	2021-02-09	2021-02-09	1,405,583	—	$0	0	SEC↗
TERN Terns Pharmaceuticals, Inc	C Conversion deriv	2021-02-09	2021-02-09	1,392,857	—	$0	0	SEC↗
TERN Terns Pharmaceuticals, Inc	C Conversion deriv	2021-02-09	2021-02-09	334,318	—	$0	0	SEC↗
TERN Terns Pharmaceuticals, Inc	C Conversion deriv	2021-02-09	2021-02-09	696,428	—	$0	0	SEC↗
TERN Terns Pharmaceuticals, Inc	C Conversion deriv	2021-02-09	2021-02-09	952,380	—	$0	0	SEC↗
TERN Terns Pharmaceuticals, Inc	C Conversion	2021-02-09	2021-02-09	1,392,857	—	$0	1,392,857	SEC↗
TERN Terns Pharmaceuticals, Inc	C Conversion	2021-02-09	2021-02-09	1,286,698	—	$0	1,286,698	SEC↗
TERN Terns Pharmaceuticals, Inc	C Conversion	2021-02-09	2021-02-09	696,428	—	$0	696,428	SEC↗
TERN Terns Pharmaceuticals, Inc	C Conversion	2021-02-09	2021-02-09	1,405,583	—	$0	1,405,583	SEC↗